BRCA2 and breast cancer: In this study we investigated the associations between an established PRS based on 313 variants for primary first breast cancer and contralateral breast cancer risks among BRCA1 and BRCA2 heterozygotes of European ancestry enrolled in the large international retrospective CIMBA cohort.